In GC, Fam198b has been associated with tumor advancement and drug sensitivity, working through the Phosphatidylinositol 3-Kinase/Protein Kinase B (PKB)/B-Cell Lymphoma 2 (PI3K/AKT/BCL-2) signaling pathway[47]. The gene discussed is AKT1; the disease is gastric cancer.